Using PBPK Models to Assess Fetal Drug Exposure Blog Using PBPK Models to Assess Fetal Drug Exposure The tragedy of thalidomide provides a cautionary tale about the potential for birth defects resulting…Certara2018 年 1 月 19 日
Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial Publication Treatment of Adult Chronic Indeterminate Chagas Disease with Benznidazole and Three E1224 Dosing Regimens: A Proof-of-concept, Randomised, Placebo-controlled Trial Certara2018 年 1 月 15 日
Best Practices for Developing High Quality, On Time Submissions White Paper 按时提交高质量材料的最佳做法 申办方常苦于申报规划。Read this white paper to learn how to develop…Certara2018 年 1 月 8 日
Model-informed Drug Development for Malaria Therapeutics Publication Model-informed Drug Development for Malaria Therapeutics Certara2018 年 1 月 6 日
How to Perform Level C IVIVC in Phoenix On-Demand Webinar 如何在 Phoenix 中执行 C 级 IVIVC C 级 IVIVC 研究分步指导。Certara2017 年 12 月 13 日
Prediction of Olanzapine Exposure in Individual Patients Using Physiologically-based Pharmacokinetic Modeling and Simulation Publication Prediction of Olanzapine Exposure in Individual Patients Using Physiologically-based Pharmacokinetic Modeling and Simulation Certara2017 年 11 月 30 日
Exposure-response of Veliparib to Inform Phase 2 Trial Design in Refractory or Relapsed Patients with Hematological Malignancies Publication Exposure-response of Veliparib to Inform Phase 2 Trial Design in Refractory or Relapsed Patients with Hematological Malignancies Certara2017 年 11 月 1 日
A Distributed Delay Approach for Modeling Delayed Outcomes in Pharmacokinetics and Pharmacodynamics Studies Publication A Distributed Delay Approach for Modeling Delayed Outcomes in Pharmacokinetics and Pharmacodynamics Studies Certara2017 年 10 月 30 日
Influence of Molecular Size on the Clearance of Antibody Fragments Publication Influence of Molecular Size on the Clearance of Antibody Fragments Certara2017 年 10 月 1 日
Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach Publication Clinical Pharmacology Tools and Evaluations to Facilitate Comprehensive Dose Finding in Oncology: A Continuous Risk-Benefit Approach Certara2017 年 9 月 15 日